Benefits of Tamper-Evident Pharmaceutical Packaging for the GLP-1 Industry

Tamper-evident pharmaceutical packaging helps patients and pharmacists confirm that no one has opened or altered a GLP-1 product before use. Counterfeiters target semaglutide and tirzepatide, and they copy the labels, cartons, and inserts along with the pen. A torn tear strip, a broken seal, or a misprinted carton gives the person holding the box a clear reason to stop and check the product. For GLP-1 brands, specialty pharmacies, and DTC platforms, tamper-evident cartons and labels are a practical way to make tampering easier to spot.

Tamper-Evident Pharmaceutical Packaging Helps Patients Spot Counterfeit GLP-1s

In December 2023, the FDA reported that it had seized thousands of counterfeit Ozempic 1 mg units from the U.S. drug supply chain. FDA confirmed that the needles, the pen label, the health care professional and patient information, and the carton were all counterfeit. The agency reported more seizures of counterfeit Ozempic in April 2025 and December 2025.

Three of the four counterfeit components FDA confirmed were printed packaging. Counterfeiters copied them closely enough to reach the legitimate supply chain. Pharmaceutical packaging is the first thing a pharmacist or patient checks, so the carton and label need features that are hard to copy. FDA's page on unapproved GLP-1 drugs, updated October 1, 2026, also lists broken or damaged packaging, spelling errors on labels, and missing instructions for use as red flags.

Novo Nordisk published tips to help patients identify a counterfeit pen. Several of the tips involve the packaging:

• A counterfeit label may be poor quality and may not stick well to the pen.
• A counterfeit carton may have spelling errors on the front.
• A counterfeit carton may not include the tamper-resistant perforation.
• The batch number on a counterfeit carton may not match the strength printed on the box and pen.

These checks work only when the genuine packaging looks the same on every carton.

Tamper-Evident Features for GLP-1 Pharmaceutical Packaging

Three features cover most tamper-evidence needs for GLP-1 pharmaceutical packaging:

• Perforated tear strips. The strip tears the first time someone opens the carton. A torn or missing strip shows the pharmacist or patient that someone already opened it. The strip is part of the paperboard, so it adds no extra material.
• Void labels and seals. A void seal across the carton flap leaves a visible pattern or torn fibers when someone peels it off. No one can reapply it without leaving visible damage.
• Consistent print quality. Accurate color, precise registration, and correct spelling on every carton make a copy easier to notice. Print the lot number and expiration date in the same position on every carton so pharmacists and patients can match them to the strength.

Seal both ends of the carton. A tear strip on one end does little if someone can open the other end and close it again. For a tuck-end carton, use a tear strip on one end and a void seal or glued closure on the other.

Anti-counterfeiting packaging can also use overt and covert security features. Color-changing inks look different when you tilt the carton. UV-reactive inks and hidden marks let your brand protection team check a suspect unit with a handheld UV light.

Smart pharmaceutical containers add a digital check. At CPHI Milan in October 2026, Schreiner MediPharm showed a GLP-1 pen label that covers part of the pen cap and leaves a permanent mark when someone opens the pen. Labels with NFC chips or scannable codes let pharmacists and patients check a product with a phone.

How Tamper Evidence Fits Drug Packaging Regulations

Drug packaging regulations treat tamper evidence differently in the U.S. and the EU.

• U.S. FDA's tamper-evident packaging rule, 21 CFR 211.132, applies to over-the-counter drugs sold at retail. It doesn't cover prescription GLP-1s, so in the U.S., tamper evidence on prescription pharmaceutical packaging is largely the brand's decision.
• EU. Since February 9, 2019, EU rules under the Falsified Medicines Directive have required most prescription medicines to carry a unique identifier and an anti-tampering device on the outer packaging. GLP-1 products sold in the EU need both.
• DSCSA. The Drug Supply Chain Security Act requires package-level tracing of prescription drugs in the U.S. through a 2D barcode on the carton. Place seals and tear strips so they don't cover or tear the barcode.

Tamper evidence on the carton doesn't replace sterile packaging. The pen or vial has its own sterile barrier, and the carton protects it during shipping and storage. Our guide to the seven types of medical packaging explains how primary, secondary, and tertiary packaging each work.

Tamper-Evident Packaging That Patients Can Open

Patient-centric packaging makes the tamper check easy to see and easy to open. GLP-1 patients often open a new carton every week, and some have limited hand strength. Give the tear strip a clear pull tab, a printed arrow, and a short line such as "Do not use if seal is broken" in large type. Clear, readable pharmaceutical packaging helps patients notice a broken seal before they use the product. Our post on medical packaging for arthritic hands and second languages covers more of these design details.

Specialty pharmacies inspect cartons when shipments arrive, so they can catch a broken seal at receiving. In a DTC order, the patient is often the only person who checks the carton after it leaves the pharmacy. Print a one-line seal check on the welcome insert so patients know what an intact carton looks like.

Tamper-evident features can also support sustainable pharma packaging. Paperboard tear strips and glue seals protect the carton without a plastic shrink band, and the EU's packaging waste rules push outer cartons toward recyclable materials.

Choose a print partner with security printing capabilities and documented quality systems. Oliver, for example, lists tamper-evident closures and labels, color-changing inks, and UV-reactive inks among its capabilities and holds ISO 9001 certification. For how packaging protects the drug itself, see our post on why packaging is part of the dose.

Check Your Pharmaceutical Packaging Before the Next Print Run

Before your next print run, check a carton from current stock against Novo Nordisk's counterfeit tips:

• Confirm the carton has a tamper-evident perforation or seal.
• Confirm the batch number is easy to read and matches the strength on the label.
• Compare the spelling, color, and registration against the approved proof.

Then decide which features to add: a tear strip, a void label, a security ink, or a scannable code. Each one makes tampering easier to spot in your pharmaceutical packaging.